Innovative Biotechnologies International

INNOVATIVE BIOTECHNOLOGIES INTERNATIONAL, INC., 335 LANG BLVD
Grand Island, NY 14072

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.51MM
First Award Date 06/01/00
Most Recent Award Date 02/01/08

Key Personnel

Last Name Name Awards Contact
Montagna Richard A. Montagna 7 Message

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 02/01/08 - 12/31/08

DESCRIPTION (provided by applicant): This SBIR Phase I application will focus on the development of a simple and inexpensive, handheld, battery-operated biosensor integrating microfluidics and molecular biology to rapidly detect Mycobacterium tuberculosis, the etiologic agent of tuberculosis (TB) in humans. With as many as 9 million new cases of...

Phase 1 SBIR

Agency: Environmental Protection Agency
Topic: 2006
Budget: 01/01/06 - 12/31/06

We have previously reported a simple method to detect viable Cryptosporidium parvum oocysts in drinking water using the isothermic Nucleic Acid Sequence Based Amplification (NASBA) method, coupled with a rapid liposme nanovesicle (Nanozome)-based biosensor technology. This assay system is based upon the ability to immunocapture low numbers (i.e...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-25
Budget: 04/01/05 - 03/31/06

DESCRIPTION (provided by applicant): In order to reduce escalating health care costs, rapid "point-of-care" (POC) testing has dramatically grown over the last decade. Due to their relative ease, immunologic approaches are frequently used for such tests. Molecular analysis (i.e., based upon DNA and/or RNA), however, has largely been limited to t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-25
Budget: 04/01/04 - 03/31/05

DESCRIPTION (provided by applicant): In order to reduce escalating health care costs, rapid "point-of-care" (POC) testing has dramatically grown over the last decade. Due to their relative ease, immunologic approaches are frequently used for such tests. Molecular analysis (i.e., based upon DNA and/or RNA), however, has largely been limited to t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/03 - 08/31/04

DESCRIPTION (provided by applicant): Up to 100 million Dengue virus infections occur annually world wide. Associated pathologies (Dengue Hemorrhagic Fever, Dengue Shock Syndrome) result in >20,000 deaths annually, primarily in children. Dengue virus is endemic to tropical/subtropical regions, with high inciden...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/15/02 - 02/28/03

DESCRIPTION (provided by applicant): Up to 100 million Dengue virus infections occur annually world wide. Associated pathologies (Dengue Hemorrhagic Fever, Dengue Shock Syndrome) result in >20,000 deaths annually, primarily in children. Dengue virus is endemic to tropical/subtropical regions, with high inciden...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/00 - 11/30/00

Dengue virus is the etiological agent responsible for Dengue Fever (DF), Dengue Hemorrhagic Fever (DHF), and Dengue Shock Syndrome (DSS). There are 50-100 million cases of DF annually worldwide, primarily in tropical and sub-tropical regions. Recent outbreaks in the Americas have occurred. Currently, there are no diagnostic assays commercially...